Wilkerson Advisory Group’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
Wilkerson Advisory Group's VRTX Position: Q2 2026 in Review
Wilkerson Advisory Group increased its Vertex Pharmaceuticals (VRTX) stake by 4.2% in Q2 2026, buying an estimated $886 and bringing the position to 50 shares worth $24.8K. The position accounts for 0.01% of the portfolio, ranked #305.
Wilkerson Advisory Group first reported a position in VRTX in Q4 2025 and has held it in 3 quarters since. 1,762 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.
- Wilkerson Advisory Group held 50 shares of Vertex Pharmaceuticals worth $24.8K as of Q2 2026.
- Wilkerson Advisory Group bought 2 Vertex Pharmaceuticals shares in Q2 2026, an estimated $886.
- Vertex Pharmaceuticals made up 0.01% of Wilkerson Advisory Group's portfolio in Q2 2026, its #305 holding.
- Wilkerson Advisory Group first reported a position in Vertex Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
- 1,762 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.
Based on Wilkerson Advisory Group's 13F filing for Q2 2026, filed 21 Jul 2026.